Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II

Autor: Carlie Delaine, John C. Wallace, Grant W. Booker, Clair L. Alvino, Briony E. Forbes, Kerrie A. McNeil, Shee Chee Ong
Rok vydání: 2011
Předmět:
Bacterial Diseases
Anatomy and Physiology
Physiology
medicine.medical_treatment
lcsh:Medicine
Biochemistry
Receptor
IGF Type 1

Mice
Estrogen-related receptor alpha
Insulin-like growth factor
0302 clinical medicine
Insulin receptor substrate
Molecular Cell Biology
Insulin
5-HT5A receptor
Insulin-Like Growth Factor I
Phosphorylation
Biomacromolecule-Ligand Interactions
lcsh:Science
Insulin-like Growth Factor
0303 health sciences
Multidisciplinary
Mycobacterium Avium Complex
3. Good health
Cell biology
Infectious Diseases
030220 oncology & carcinogenesis
Medicine
Protein Binding
Signal Transduction
Research Article
Molecular Sequence Data
Biophysics
Endocrine System
Biology
Binding
Competitive

Protein Chemistry
Cell Growth
03 medical and health sciences
Growth factor receptor
Insulin-Like Growth Factor II
medicine
Enzyme-linked receptor
Animals
Amino Acid Sequence
Molecular Biology
Enzyme Assays
030304 developmental biology
Insulin-like growth factor 1 receptor
Endocrine Physiology
lcsh:R
Proteins
Cell Biology
Receptor
Insulin

Hormones
Enzyme Activation
Insulin receptor
biology.protein
Mutant Proteins
lcsh:Q
Proto-Oncogene Proteins c-akt
Sequence Alignment
Zdroj: PLoS ONE, Vol 6, Iss 11, p e27488 (2011)
PLoS ONE
ISSN: 1932-6203
Popis: Background Insulin-like growth factor-II (IGF-II) promotes cell proliferation and survival and plays an important role in normal fetal development and placental function. IGF-II binds both the insulin-like growth factor receptor (IGF-1R) and insulin receptor isoform A (IR-A) with high affinity. Interestingly both IGF-II and the IR-A are often upregulated in cancer and IGF-II acts via both receptors to promote cancer proliferation. There is relatively little known about the mechanism of ligand induced activation of the insulin (IR) and IGF-1R. The recently solved IR structure reveals a folded over dimer with two potential ligand binding pockets arising from residues on each receptor half. Site-directed mutagenesis has mapped receptor residues important for ligand binding to two separate sites within the ligand binding pocket and we have recently shown that the IGFs have two separate binding surfaces which interact with the receptor sites 1 and 2. Methodology/Principal Findings In this study we describe a series of partial IGF-1R and IR agonists generated by mutating Glu12 of IGF-II. By comparing receptor binding affinities, abilities to induce negative cooperativity and potencies in receptor activation, we provide evidence that residue Glu12 bridges the two receptor halves leading to receptor activation. Conclusions/Significance This study provides novel insight into the mechanism of receptor binding and activation by IGF-II, which may be important for the future development of inhibitors of its action for the treatment of cancer.
Databáze: OpenAIRE